Dimensional Fund Advisors’s Ocular Therapeutix OCUL Stock Holding History

Dimensional Fund Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.49M	Buy	+649,756	New	+$6.19M	﹤0.01%	2468
2024 Q1	–	Sell	-12,389	Closed	-$55.3K	–	3422
2023 Q4	$55.3K	Hold	12,389	–	–	﹤0.01%	3341
2023 Q3	$38.9K	Sell	12,389 -11,930	-49%	-$48.8K	﹤0.01%	3399
2023 Q2	$125K	Hold	24,319	–	–	﹤0.01%	3299
2023 Q1	$128K	Sell	24,319 -210,464	-90%	-$999K	﹤0.01%	3273
2022 Q4	$660	Buy	234,783 +88,661	+61%	+$294K	﹤0.01%	2991
2022 Q3	$607K	Buy	146,122 +38,310	+36%	+$193K	﹤0.01%	2998
2022 Q2	$434K	Buy	107,812 +91,089	+545%	+$344K	﹤0.01%	3095
2022 Q1	$83K	Hold	16,723	–	–	﹤0.01%	3413
2021 Q4	$117K	Buy	+16,723	New	+$130K	﹤0.01%	3415
2019 Q4	–	Sell	-11,423	Closed	-$35K	–	3400
2019 Q3	$35K	Hold	11,423	–	–	﹤0.01%	3401
2019 Q2	$50K	Sell	11,423 -12,408	-52%	-$45.9K	﹤0.01%	3427
2019 Q1	$95K	Hold	23,831	–	–	﹤0.01%	3379
2018 Q4	$95K	Sell	23,831 -5,259	-18%	-$29K	﹤0.01%	3360
2018 Q3	$200K	Buy	+29,090	New	+$183K	﹤0.01%	3308
2018 Q1	–	Sell	-39,664	Closed	-$177K	–	3355
2017 Q4	$177K	Hold	39,664	–	–	﹤0.01%	3235
2017 Q3	$245K	Buy	+39,664	New	+$255K	﹤0.01%	3193

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors's OCUL Position: Q1 2026 in Review

Dimensional Fund Advisors opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 649,756 shares worth $5.49M. The stake represents ﹤0.01% of the portfolio and ranks #2468 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in OCUL as recently as Q4 2023.

Dimensional Fund Advisors first reported a position in OCUL in Q3 2017 and has held it in 17 quarters since. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

Dimensional Fund Advisors held 649,756 shares of Ocular Therapeutix worth $5.49M as of Q1 2026.
Ocular Therapeutix was a new Dimensional Fund Advisors position in Q1 2026.
Ocular Therapeutix made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2468 holding.
Dimensional Fund Advisors first reported a position in Ocular Therapeutix in Q3 2017 and has held it in 17 quarters since.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.